StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
ONCOOnconetix, Inc.
stockpulse.co.kr
NasdaqOn RegSHO · 18 days in a row
$0.4061▼ 1.26%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $1.5MShares out 3.7M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

34
  • 1d agoRegular26.10.24 00:42
    DEFA14AOther#●●●

    Onconetix, Inc.

    Onconetix, Inc. provided an additional $500,000 advance to Realbotix, LLC on October 22, 2026. This brings the total aggregate principal amount outstanding under the previously disclosed promissory note to $3.0 million.…more

    $0.4061-1.26%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 1d agoRegular26.10.24 00:40
    8-KKey event

    Onconetix, Inc.

    Onconetix, Inc. has provided an additional $500,000 advance to Realbotix, LLC. Following this transaction, the aggregate principal amount outstanding under the existing Grid Promissory Note has reached $3.0 million.…more

    $0.4061-1.26%vs prev close
    View filingShare
  • 2d agoPre-market26.10.23 22:22
    425Other

    Onconetix, Inc.

    Onconetix has provided an additional $500,000 advance to Realbotix, bringing the total outstanding principal under their strategic bridge financing facility to $3,000,000. This facility will be automatically cancelled and discharged in full upon the closing of the pending acquisition.…more

    $0.4061-1.26%vs prev close
    View filingShare

33 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire
  • 2d agoPre-market26.10.23 21:30
    #●●●#●●●

    Onconetix Provides Additional $500K Bridge Financing to Realbotix

    Onconetix has provided an additional $500,000 in bridge financing to Realbotix, bringing the total facility to $3 million. This funding supports the pending acquisition and will be automatically discharged upon the deal's closing.…more

    $0.4061-1.26%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    Read sourceShareGlobeNewswire
  • 9.14Regular26.09.15 01:50

    ●●●●●●●● ●●●●● ●●●●●●

    Onconetix has provided a bridge financing facility of up to $5 million to support Realbotix as they move toward their pending acquisition. The facility will be automatically discharged upon the successful closing of the acquisition deal.…more

    $0.4061-1.26%vs prev close
    Read sourceShareGlobeNewswire
  • 9.14Pre-market26.09.14 21:30

    ●●●●●●●● ●●●●● ●●●●●●

    Onconetix is providing up to $5 million in bridge financing to support the operations of its acquisition target, Realbotix. The facility is designed to facilitate the pending merger and will be discharged upon the successful closing of the transaction.…more

    $0.4061-1.26%vs prev close
    Read sourceShareGlobeNewswire

2 more news items

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →